Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Postgraduate Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0022-3859.39183PMID 18296798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study

  2007cited by this paper
• Tissue Doppler Imaging

  2007cited by this paper
• Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides.

  2007cited by this paper
• Amount of left ventricular hypertrophy determines the plasma N‐terminal pro‐brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction

  2006cited by this paper
• N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.

  2006cited by this paper
• Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine

  2005cited by this paper
• Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.

  2005cited by this paper
• Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration.

  2005cited by this paper
• Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function : role of B-type natriuretic peptide ded from

  2004cited by this paper
• Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis

  2004cited by this paper
• Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.

  2004cited by this paper
• Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.

  2004cited by this paper
• Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis

  2003cited by this paper
• Plasma N‐terminal pro BNP and cardiotrophin‐1 are elevated in aortic stenosis

  2001cited by this paper
• Natriuretic peptides in patients with aortic stenosis.

  2001cited by this paper
• Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging.

  1998cited by this paper
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

  1998cited by this paper
• Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

  1996cited by this paper
• The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta.

  1996cited by this paper
• Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

  1995cited by this paper
• Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure

  1993cited by this paper
• Brain natriuretic peptide as a cardiac hormone in essential hypertension.

  1992cited by this paper
• Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy.

  1992cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method

  1977cited by this paper

• Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.

  2022cites this paper
• Evaluation of left ventricular diastolic function in patients operated for aortic stenosis

  2022cites this paper
• The association of left ventricular histologically verified myocardial fibrosis with pulmonary hypertension in severe aortic stenosis

  2021cites this paper
• The value of brain natriuretic peptide in the prosthetic valve thrombosis

  2020cites this paper
• Evaluation of plasma N-terminal pro-brain natriuretic peptide and troponin I concentrations in dogs with congenital ventricular outflow tract stenosis

  2016cites this paper
• Natriuretic peptides for risk stratification of patients with valvular aortic stenosis.

  2015cites this paper
• Relation between E/e’ ratio and NT-proBNP levels in elderly patients with symptomatic severe aortic stenosis

  2015cites this paper
• Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis

  2014cites this paper
• Clinical outcome, echocardiographic assessment, neurohormonal and collagen turnover markers in low-fl ow severe aortic stenosis with high transvalvular gradient.

  2014cites this paper
• Copeptin constitutes a novel biomarker of degenerative aortic stenosis

  2013cites this paper
• Diagnostic value of NT-proBNP in identifying impaired coronary flow reserve in asymptomatic moderate or severe aortic stenosis.

  2013cites this paper
• Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).

  2011cites this paper
• Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.

  2011influential citation
• Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings

  2010cites this paper
• Natriuretic peptides in common valvular heart disease.

  2010cites this paper
• Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement

  2010cites this paper